Search results
Author(s):
Luigi Di Biase
Added:
1 year ago
AF Symposium 25 - Insights from the admIRE sub-analysis show that if a patient experiences an early recurrence of paroxysmal atrial fibrillation (PAF), they are likely to experience another recurrence, suggesting that the blanking period is not needed in pulsed field ablation (PFA).Dr Luigi Di Biase (Albert Einstein College of Medicine and Montefiore Medical Center, NY, US) joins us onsite at AF…
View more
Author(s):
Else Sandset
,
Jesse Dawson
,
Urs Fischer
,
et al
Added:
2 years ago
Dr Else Sandset (Oslo University Hospital, NO) is joined by Prof Jesse Dawson (University of Glasgow, GB), Dr Urs Fischer (University Hospital Basel, CH) and Dr Masatoshi Koga (National Cerebral and Cardiovascular Center, JP) to discuss the findings from their recent paper on "Early versus Later Anticoagulation for Stroke with Atrial Fibrillation" published in the New England Journal of Medicine…
View more
Added:
7 months ago
Source:
Radcliffe CVRM
A prespecified secondary analysis of the EAST-AFNET 4 trial has found that the benefits of an early rhythm control strategy for patients with recently diagnosed atrial fibrillation (AF) are maintained regardless of whether patients have obesity or diabetes.¹ These findings suggest that clinicians should not withhold this therapeutic approach based on these common metabolic comorbidities.The…
View more
Author(s):
Jack McCready
,
Richard Balasubramaniam
,
Added:
4 months ago
Real-world perspectives from PulseSelect™ and Affera™With lots of new pulsed-field ablation (PFA) technology becoming available, one key question emerges: How are these systems performing in real-world clinical practice? This on-demand version of the session takes you inside the lab to share practical perspectives from physicians at the forefront of PFA adoption.Chaired by Dr Jack McCready…
View more
Author(s):
Jack McCready, Richard Balasubramaniam, Sandeep Panikker
Start date:
Nov 07, 2025
Real-world perspectives from PulseSelect™ and Affera™With lots of new pulsed-field ablation (PFA) technology becoming available, the most important question becomes: How are they performing in the real-world? This session will dive into the lab to share practical perspectives from physicians at the forefront of adoption. Join Dr Jack McCready(University Hospitals Sussex NHS Foundation Trust, UK)…
View more
Ventricular Tachycardia After Cardioversion
Author(s):
Eiad Habib
,
Mahmoud Abdelnabi
,
Ramzi Ibrahim
,
et al
Added:
3 months ago
Case Report
Investigation of the Unexplained Cardiac Arrest Survivor
Author(s):
Gonca Suna
,
Greg J Mellor
Added:
2 years ago
Review Article
Author(s):
Devi Nair
Added:
2 weeks ago
AF Symposium 2026 - Dr Devi Nair (St Bernards Heart & Vascular, US) joins us to discuss early outcomes from the VERITAS Study, evaluating Abbott's next-generation Amulet 360™ Left Atrial Appendage Occluder for stroke prevention in patients with non-valvular atrial fibrillation.This pivotal study enrolled 400 patients across 34 centers in the United States, Canada, and Europe. Findings presented…
View more
Author(s):
Marat Fudim
,
David Duncker
Added:
2 weeks ago
In this episode of Arrhythmia Academy's Journal Club, Dr David Duncker (Hannover Heart Rhythm Center, DE) is joined by Dr Marat Fudim (Duke University, US) to examine the critical early-risk period following heart failure diagnosis and the emerging role of wearable cardioverter defibrillators in sudden cardiac death prevention.The discussion centres on findings from the SCD-PROTECT study, a 19…
View more
Overview of Genetic Risk Factors and Aetiologies
Author(s):
Sarah Ming Li Tan
,
Shir Lynn Lim
,
Marcus EH Ong
,
et al
Added:
6 months ago
Review Article